Category Pharmaceuticals
Just Price for Drugs: The eleventh hour
Marc-André Gagnon urges modernization and fairness in the pricing of patented drugs in Canada
Monopolies on New Medicines & Trade with the U.S.
Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.
Pharmacare: Improving Access to Expensive Drugs
Marc-André Gagnon dispels misconceptions about the benefits of private health insurance plans and argues in favour of a universal model for pharmacare.
Clean Needle Pilot Programs at 2 Federal Prisons
Chelsea Cox comments on the introduction of two clean needle exchange pilot programs in Canadian prisons.
Responding to the Opioid Epidemic
Matthew Herder considers possible regulatory responses to the opioid epidemic that aim to recover health care costs, compensate survivors, or prosecute pharmaceutical companies.
Impact Ethics 